Robin Swartz, COO and CBO of Voyager Therapeutics ($VYGR), sold shares on the open market three times over the past year for a total of about $55,300. Her most recent sale was on February 24, 2026. These transactions rank 10,289th out of 11,678 insiders by sale value, well below the average of $8.6 million across 6.4 transactions per insider. Swartz made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 24, 2026 | Voyager Therapeutics, Inc. | $VYGR | Swartz Robin | COO & CBO | S | Common Stock | 6458 | $3.77 | 199,738.0000 | 58,803,015 | 3.13% | 0.01% |
| Feb. 18, 2026 | Voyager Therapeutics, Inc. | $VYGR | Swartz Robin | COO & CBO | S | Common Stock | 3882 | $3.44 | 206,196.0000 | 58,803,015 | 1.85% | 0.01% |
| Feb. 10, 2026 | Voyager Therapeutics, Inc. | $VYGR | Swartz Robin | COO & CBO | S | Common Stock | 4569 | $3.85 | 210,078.0000 | 58,803,015 | 2.13% | 0.01% |
| Feb. 6, 2026 | Voyager Therapeutics, Inc. | $VYGR | Swartz Robin | COO & CBO | A | Stock Option (Right to Buy) | 210000 | $0.00 | 210,000.0000 | 58,803,015 | 9999.99% | 0.36% |
| Feb. 6, 2026 | Voyager Therapeutics, Inc. | $VYGR | Swartz Robin | COO & CBO | A | Common Stock | 45000 | $0.00 | 214,647.0000 | 58,803,015 | 26.53% | 0.08% |
| Feb. 20, 2025 | Voyager Therapeutics, Inc. | $VYGR | Swartz Robin | COO & CBO | S | Common Stock | 3894 | $4.25 | 98,397.0000 | 57,667,543 | 3.81% | 0.01% |
| Feb. 21, 2025 | Voyager Therapeutics, Inc. | $VYGR | Swartz Robin | COO & CBO | A | Common Stock | 71250 | $0.00 | 169,647.0000 | 57,667,543 | 72.41% | 0.12% |
| Feb. 21, 2025 | Voyager Therapeutics, Inc. | $VYGR | Swartz Robin | COO & CBO | A | Stock Option (Right to Buy) | 142500 | $0.00 | 142,500.0000 | 57,667,543 | 9999.99% | 0.25% |
| Feb. 11, 2025 | Voyager Therapeutics, Inc. | $VYGR | Swartz Robin | COO & CBO | S | Common Stock | 6950 | $4.45 | 102,291.0000 | 57,667,543 | 6.36% | 0.01% |
| Jan. 14, 2025 | Voyager Therapeutics, Inc. | $VYGR | Swartz Robin | COO & CBO | S | Common Stock | 3087 | $5.09 | 109,241.0000 | 57,667,543 | 2.75% | 0.01% |
| Dec. 23, 2024 | Voyager Therapeutics, Inc. | $VYGR | Swartz Robin | COO&CBO | S | Common Stock | 6500 | $5.65 | 112,328.0000 | 57,851,110 | 5.47% | 0.01% |
| April 2, 2024 | Voyager Therapeutics, Inc. | $VYGR | Swartz Robin | Chief Operating Officer | S | Common Stock | 1357 | $9.88 | 117,004.0000 | 57,117,046 | 1.15% | 0.00% |
| Feb. 21, 2024 | Voyager Therapeutics, Inc. | $VYGR | Swartz Robin | Chief Operating Officer | S | Common Stock | 3966 | $7.45 | 118,361.0000 | 44,569,334 | 3.24% | 0.01% |
| Feb. 9, 2024 | Voyager Therapeutics, Inc. | $VYGR | Swartz Robin | Chief Operating Officer | A | Common Stock | 50000 | $0.00 | 122,327.0000 | 44,569,334 | 69.13% | 0.11% |
| Feb. 9, 2024 | Voyager Therapeutics, Inc. | $VYGR | Swartz Robin | Chief Operating Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 44,569,334 | 9999.99% | 0.22% |
| Jan. 17, 2024 | Voyager Therapeutics, Inc. | $VYGR | Swartz Robin | Chief Operating Officer | S | Common Stock | 2543 | $7.15 | 72,327.0000 | 44,569,334 | 3.40% | 0.01% |
| April 3, 2023 | Voyager Therapeutics, Inc. | $VYGR | Swartz Robin | Chief Operating Officer | S | Common Stock | 1259 | $7.83 | 71,617.0000 | 42,161,326 | 1.73% | 0.00% |
| March 20, 2023 | Voyager Therapeutics, Inc. | $VYGR | Swartz Robin | Chief Operating Officer | S | Common Stock | 3654 | $7.76 | 72,876.0000 | 38,356,810 | 4.77% | 0.01% |
| March 15, 2023 | Voyager Therapeutics, Inc. | $VYGR | Swartz Robin | Chief Operating Officer | S | Common Stock | 15373 | $8.20 | 76,530.0000 | 38,356,810 | 16.73% | 0.04% |
| Feb. 17, 2023 | Voyager Therapeutics, Inc. | $VYGR | Swartz Robin | Chief Operating Officer | A | Stock Option (Right to Buy) | 80000 | $0.00 | 80,000.0000 | 38,356,810 | 9999.99% | 0.21% |
| Feb. 17, 2023 | Voyager Therapeutics, Inc. | $VYGR | Swartz Robin | Chief Operating Officer | A | Common Stock | 40000 | $0.00 | 91,903.0000 | 38,356,810 | 77.07% | 0.10% |
| Jan. 17, 2023 | Voyager Therapeutics, Inc. | $VYGR | Swartz Robin | Chief Operating Officer | S | Common Stock | 792 | $10.34 | 51,903.0000 | 38,356,810 | 1.50% | 0.00% |
| Jan. 17, 2023 | Voyager Therapeutics, Inc. | $VYGR | Swartz Robin | Chief Operating Officer | S | Common Stock | 1396 | $9.57 | 52,695.0000 | 38,356,810 | 2.58% | 0.00% |